FDA inspection
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.: FDA inspection ending Feb 22, 2019
FDA inspection 1082504 · No Action Indicated (NAI) · Nanjing
Key facts
| Inspection ID | 1082504 |
|---|---|
| Firm | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. |
| FEI number | 3010625707 |
| Address | No. 16 Xuefu Rd., Nanjing High & New Technology Developmen |
| City | Nanjing |
| Fiscal year | 2019 |
| Inspection end date | Feb 22, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data